232 related articles for article (PubMed ID: 25046176)
1. Multiple receptor conformation docking, dock pose clustering and 3D QSAR studies on human poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Fatima S; Jatavath MB; Bathini R; Sivan SK; Manga V
J Recept Signal Transduct Res; 2014 Oct; 34(5):417-30. PubMed ID: 25046176
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
Zeng H; Zhang H; Jang F; Zhao L; Zhang J
Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking and 3D-QSAR studies on inhibitors of DNA damage signaling enzyme human PARP-1.
Fatima S; Bathini R; Sivan SK; Manga V
J Recept Signal Transduct Res; 2012 Aug; 32(4):214-24. PubMed ID: 22713102
[TBL] [Abstract][Full Text] [Related]
4. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
Halder AK; Saha A; Saha KD; Jha T
J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
[TBL] [Abstract][Full Text] [Related]
5. Active site fingerprinting and pharmacophore screening strategies for the identification of dual inhibitors of protein kinase C (ΡΚCβ) and poly (ADP-ribose) polymerase-1 (PARP-1).
Chadha N; Silakari O
Mol Divers; 2016 Aug; 20(3):747-61. PubMed ID: 27216445
[TBL] [Abstract][Full Text] [Related]
6. Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis.
Costantino G; Macchiarulo A; Camaioni E; Pellicciari R
J Med Chem; 2001 Nov; 44(23):3786-94. PubMed ID: 11689065
[TBL] [Abstract][Full Text] [Related]
7. Structural Requirements of Some 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide Derivatives as Poly (ADP-Ribose) Polymerase (PARP) for the Treatment of Cancer: QSAR Approach.
Sharma MC
Interdiscip Sci; 2016 Mar; 8(1):11-22. PubMed ID: 26205198
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors.
Chadha N; Jaggi AS; Silakari O
Mol Divers; 2017 Aug; 21(3):655-660. PubMed ID: 28653128
[TBL] [Abstract][Full Text] [Related]
9. Probing PARP1-inhibitor complexes for the development of novel inhibitors.
Saqib U; Baig MS
Cell Mol Biol (Noisy-le-grand); 2014 Oct; 60(3):43-52. PubMed ID: 25346248
[TBL] [Abstract][Full Text] [Related]
10. Exploring the effect of PARP-1 flexibility in docking studies.
Antolin AA; Carotti A; Nuti R; Hakkaya A; Camaioni E; Mestres J; Pellicciari R; Macchiarulo A
J Mol Graph Model; 2013 Sep; 45():192-201. PubMed ID: 24056306
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
Hannigan K; Kulkarni SS; Bdzhola VG; Golub AG; Yarmoluk SM; Talele TT
Bioorg Med Chem Lett; 2013 Nov; 23(21):5790-4. PubMed ID: 24074844
[TBL] [Abstract][Full Text] [Related]
12. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase.
Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC
Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2.
Oliver AW; Amé JC; Roe SM; Good V; de Murcia G; Pearl LH
Nucleic Acids Res; 2004; 32(2):456-64. PubMed ID: 14739238
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
Parsons JL; Dianova II; Allinson SL; Dianov GL
FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
[TBL] [Abstract][Full Text] [Related]
15. [Construction of pharmacophore model of PARP-1 inhibitor].
Zhang WT; Yan H; Jiang FC
Yao Xue Xue Bao; 2007 Mar; 42(3):279-85. PubMed ID: 17520827
[TBL] [Abstract][Full Text] [Related]
16. Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studies.
Abbasi-Radmoghaddam Z; Riahi S; Gharaghani S; Mohammadi-Khanaposhtanai M
Mol Divers; 2021 Feb; 25(1):263-277. PubMed ID: 32140890
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR, molecular docking, and molecular dynamics analysis of dihydrodiazaindolone derivatives as PARP-1 inhibitors.
Zhao J; Yu N; Zhao X; Quan W; Shu M
J Mol Model; 2023 Apr; 29(5):131. PubMed ID: 37020092
[TBL] [Abstract][Full Text] [Related]
18. Modeling of the Enzyme-Substrate Complexes of Human Poly(ADP-Ribose) Polymerase 1.
Nilov DK; Pushkarev SV; Gushchina IV; Manasaryan GA; Kirsanov KI; Švedas VK
Biochemistry (Mosc); 2020 Jan; 85(1):99-107. PubMed ID: 32079521
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors.
Yao H; Ji M; Zhu Z; Zhou J; Cao R; Chen X; Xu B
Bioorg Med Chem; 2015 Feb; 23(4):681-93. PubMed ID: 25614115
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
Dantzer F; Amé JC; Schreiber V; Nakamura J; Ménissier-de Murcia J; de Murcia G
Methods Enzymol; 2006; 409():493-510. PubMed ID: 16793420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
